Elucidating the specific pharmacological mechanism of motion (MOA) of In a natural way developing compounds can be demanding. Though Tarselli et al. (60) developed the first de novo artificial pathway to conolidine and showcased that this In a natural way happening compound efficiently suppresses responses to both of those chemically induced and in